My group sits at the intersection of genomics and neuroscience, utilising a number of genomic approaches (RNA-Seq, long-read sequencing, targeted RNA sequencing and single cell sequencing) to investigate gene expression and function in the human brain and in neuropsychiatric disorders. Many regions in our DNA are known to confer risk to disease, including neuropsychiatric disorders, but the genes responsible and how they confer risk are often unknown.
We are interested in identifying these genes (both protein coding and noncoding) and how their expression can change to cause disease risk. We utilise both post-mortem human brain and neurons derived from induced pluripotent stem cells (iPSCs) to help answer these questions.
A second research interest of my group is to develop and utilise novel sequencing methods. We have worked in the past to help develop targeted RNA sequencing to allow highly sensitive detection and quantification of genes of interest. More recently we have focused on utilising Nanopore sequencing, a technology that can sequence both DNA and native RNA. We are very interested in applying Nanopore sequencing to many research questions and in developing novel applications for this technology.
In addition I have long-standing interests in multiple aspects of RNA biology including noncoding RNAs and RNA post-transcriptional regulation.
Find out more about Mike Clark's experience
Mike Clark's highlights
FEATURED Journal article
Long-read sequencing reveals the complex splicing profile of the psychiatric risk gene CACNA1C in human brain
Read moreMike Clark's selected work
Projects
Displaying the 4 most recent projects by Mike Clark.
Project Types
4
Research Grant
Scholarly Works
Displaying the 25 most recent scholarly works by Mike Clark.
Honours, Awards and Fellowships
Credentials
Positions
Research Fellow In Transriptomics
Anatomy And Neuroscience
Education
Genomics and Computational Biology
The University of Queensland
Biochemistry
University of Otago
Biochemistry
University of Otago